EIH Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:36 pm

Competitors of EIH Ltd

All Competitor Stocks of EIH Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:15 am

Below is a detailed analysis of the quarterly data for EIH Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 574.00 Cr.. The value appears to be declining and may need further review. It has decreased from 827.00 Cr. (Mar 2025) to 574.00 Cr., marking a decrease of 253.00 Cr..
• For Expenses, as of Jun 2025, the value is 414.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 477.00 Cr. (Mar 2025) to 414.00 Cr., marking a decrease of 63.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 160.00 Cr.. The value appears to be declining and may need further review. It has decreased from 351.00 Cr. (Mar 2025) to 160.00 Cr., marking a decrease of 191.00 Cr..
• For OPM %, as of Jun 2025, the value is 28.00%. The value appears to be declining and may need further review. It has decreased from 42.00% (Mar 2025) to 28.00%, marking a decrease of 14.00%.
• For Other Income, as of Jun 2025, the value is -66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to -66.00 Cr., marking a decrease of 109.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 33.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 355.00 Cr. (Mar 2025) to 54.00 Cr., marking a decrease of 301.00 Cr..
• For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 32.00%, marking an increase of 6.00%.
• For Net Profit, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 262.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 225.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.54. The value appears to be declining and may need further review. It has decreased from 4.04 (Mar 2025) to 0.54, marking a decrease of 3.50.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:24 am

Growth

Last Updated: September 5, 2025, 3:20 am

Balance Sheet

Last Updated: July 25, 2025, 3:18 pm

Below is a detailed analysis of the balance sheet data for EIH Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 125.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 125.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,488.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,814.00 Cr. (Mar 2024) to 4,488.00 Cr., marking an increase of 674.00 Cr..
• For Borrowings, as of Mar 2025, the value is 265.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 199.00 Cr. (Mar 2024) to 265.00 Cr., marking an increase of 66.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 953.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 906.00 Cr. (Mar 2024) to 953.00 Cr., marking an increase of 47.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,831.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,045.00 Cr. (Mar 2024) to 5,831.00 Cr., marking an increase of 786.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 3,143.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,885.00 Cr. (Mar 2024) to 3,143.00 Cr., marking an increase of 258.00 Cr..
• For CWIP, as of Mar 2025, the value is 308.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Mar 2024) to 308.00 Cr., marking an increase of 138.00 Cr..
• For Investments, as of Mar 2025, the value is 548.00 Cr.. The value appears strong and on an upward trend. It has increased from 448.00 Cr. (Mar 2024) to 548.00 Cr., marking an increase of 100.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,833.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,542.00 Cr. (Mar 2024) to 1,833.00 Cr., marking an increase of 291.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,831.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,045.00 Cr. (Mar 2024) to 5,831.00 Cr., marking an increase of 786.00 Cr..

Notably, the Reserves (4,488.00 Cr.) exceed the Borrowings (265.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for EIH Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has increased from 10.22 (Mar 24) to 11.82, marking an increase of 1.60.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has increased from 10.22 (Mar 24) to 11.82, marking an increase of 1.60.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 12.40 (Mar 24) to 13.52, marking an increase of 1.12.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.76. It has increased from 65.34 (Mar 24) to 73.76, marking an increase of 8.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.76. It has increased from 65.34 (Mar 24) to 73.76, marking an increase of 8.42.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 43.86. It has increased from 40.16 (Mar 24) to 43.86, marking an increase of 3.70.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 18.44. This value is within the healthy range. It has increased from 16.66 (Mar 24) to 18.44, marking an increase of 1.78.
• For PBIT / Share (Rs.), as of Mar 25, the value is 16.29. This value is within the healthy range. It has increased from 14.55 (Mar 24) to 16.29, marking an increase of 1.74.
• For PBT / Share (Rs.), as of Mar 25, the value is 15.50. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.50, marking an increase of 1.37.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 11.37. This value is within the healthy range. It has increased from 10.30 (Mar 24) to 11.37, marking an increase of 1.07.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has increased from 10.22 (Mar 24) to 11.82, marking an increase of 1.60.
• For PBDIT Margin (%), as of Mar 25, the value is 42.04. This value is within the healthy range. It has increased from 41.47 (Mar 24) to 42.04, marking an increase of 0.57.
• For PBIT Margin (%), as of Mar 25, the value is 37.14. This value exceeds the healthy maximum of 20. It has increased from 36.24 (Mar 24) to 37.14, marking an increase of 0.90.
• For PBT Margin (%), as of Mar 25, the value is 35.33. This value is within the healthy range. It has increased from 35.17 (Mar 24) to 35.33, marking an increase of 0.16.
• For Net Profit Margin (%), as of Mar 25, the value is 25.92. This value exceeds the healthy maximum of 10. It has increased from 25.64 (Mar 24) to 25.92, marking an increase of 0.28.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 26.95. This value exceeds the healthy maximum of 20. It has increased from 25.44 (Mar 24) to 26.95, marking an increase of 1.51.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.03. This value is within the healthy range. It has decreased from 16.22 (Mar 24) to 16.03, marking a decrease of 0.19.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.29. This value is within the healthy range. It has decreased from 20.20 (Mar 24) to 19.29, marking a decrease of 0.91.
• For Return On Assets (%), as of Mar 25, the value is 12.66. This value is within the healthy range. It has increased from 12.65 (Mar 24) to 12.66, marking an increase of 0.01.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has decreased from 0.53 (Mar 24) to 0.50, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 2.56 (Mar 24) to 2.82, marking an increase of 0.26.
• For Quick Ratio (X), as of Mar 25, the value is 2.71. This value exceeds the healthy maximum of 2. It has increased from 2.45 (Mar 24) to 2.71, marking an increase of 0.26.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 45.20. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 45.20, marking an increase of 45.20.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.14. This value is below the healthy minimum of 20. It has decreased from 10.76 (Mar 24) to 10.14, marking a decrease of 0.62.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 20. It has decreased from 8.92 (Mar 24) to 8.58, marking a decrease of 0.34.
• For Earning Retention Ratio (%), as of Mar 25, the value is 89.86. This value exceeds the healthy maximum of 70. It has increased from 89.24 (Mar 24) to 89.86, marking an increase of 0.62.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.42. This value exceeds the healthy maximum of 70. It has increased from 91.08 (Mar 24) to 91.42, marking an increase of 0.34.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 54.03. This value is within the healthy range. It has increased from 53.66 (Mar 24) to 54.03, marking an increase of 0.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 35.64. This value is within the healthy range. It has increased from 34.55 (Mar 24) to 35.64, marking an increase of 1.09.
• For Enterprise Value (Cr.), as of Mar 25, the value is 21,297.36. It has decreased from 27,572.62 (Mar 24) to 21,297.36, marking a decrease of 6,275.26.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.76. This value exceeds the healthy maximum of 3. It has decreased from 10.98 (Mar 24) to 7.76, marking a decrease of 3.22.
• For EV / EBITDA (X), as of Mar 25, the value is 18.46. This value exceeds the healthy maximum of 15. It has decreased from 26.47 (Mar 24) to 18.46, marking a decrease of 8.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.05. This value exceeds the healthy maximum of 3. It has decreased from 11.18 (Mar 24) to 8.05, marking a decrease of 3.13.
• For Retention Ratios (%), as of Mar 25, the value is 89.85. This value exceeds the healthy maximum of 70. It has increased from 89.23 (Mar 24) to 89.85, marking an increase of 0.62.
• For Price / BV (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has decreased from 7.12 (Mar 24) to 4.79, marking a decrease of 2.33.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.05. This value exceeds the healthy maximum of 3. It has decreased from 11.18 (Mar 24) to 8.05, marking a decrease of 3.13.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness